本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Design Therapeutics, Inc.

5.96
+0.23004.01%
盘后5.960.00000.00%16:10 EDT
成交量:17.48万
成交额:103.02万
市值:3.39亿
市盈率:-5.33
高:6.05
开:5.68
低:5.59
收:5.73
52周最高:7.77
52周最低:2.60
股本:5,694.81万
流通股本:2,627.76万
量比:0.85
换手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-1.1191
每股收益(LYR):-0.8763
净资产收益率:-26.77%
总资产收益率:-19.02%
市净率:1.59
市盈率(LYR):-6.80

数据加载中...

2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/20

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/09/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/06/07

重要事件披露

8-K - Current report
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/05

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933